Startups
Edit
ABAC Therapeutics
http://www.abactherapeutics.com/Last activity: 20.11.2019
Probably Closed - Reference to neoantigen-summit.com
ABAC Therapeutics is committed to finding therapeutic solutions for patients that are infected with highly antibiotic-resistant bacterial pathogens and that leave affected patients with few (or no) treatment options. Heads of national healthcare services, professional infectious diseases organizations and infectious diseases experts are warning that we are facing a return to a pre-antibiotic era. Infections with such “superbugs” are increasing in both severity and frequency, and new drugs are needed to treat them now. ABAC Therapeutics is focused on delivering new pathogen-specific antibacterials for the treatment of multi-drug resistant bugs.
Overview
Location
Spain, Catalonia, Esplugues de Llobregat
Employees
1-10
Total raised
$20M
Founded date
2014
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 16, 2018 | ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-Resistant Bacteria | ABAC Therapeutics (ABAC), a leader in pathogen-specific antibiotics, announced today the closing of a €16 million Series A round. The financing was led by Pontifax with participation from the Global Health Science Fund (jointly established ... |
| Feb 15, 2018 | Abac Therapeutics cierra ronda de €16M liderada por Pontifax, acuden Global Health, CaixaCR, Debiopharm Innovation y Ferrer | 15/02/2018 Nota de prensa ABAC THERAPEUTICS CIERRA RONDA DE €16 MILLONES LIDERADA POR PONTIFAX, ACUDEN TAMBIÉN GLOBAL HEALTH, CAIXA CAPITAL RISC, DEBIOPHARM INNOVATION Y FERRER. ABAC Therapeutics (ABAC), una compañía líder en la investig... |
Reviews 0
FAQ about ABAC Therapeutics
When was ABAC Therapeutics founded?
ABAC Therapeutics was founded in 2014.
How much funding has ABAC Therapeutics raised?
ABAC Therapeutics has raised $20M in total across 1 funding round.
What has the press written about ABAC Therapeutics?
Parsers VC has collected 3 articles mentioning ABAC Therapeutics, among them “ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-Resistant Bacteria” (Feb 16, 2018) and “Abac Therapeutics cierra ronda de €16M liderada por Pontifax, acuden Global Health, CaixaCR, Debiopharm Innovation y Ferrer” (Feb 15, 2018).
Is ABAC Therapeutics still active?
ABAC Therapeutics is probably closed: its latest activity on Parsers VC dates from Nov 20, 2019.